Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostic products, today announced the release of three new StarBright™ Red Dyes—StarBright Red 715, 775 and 815—and an extension of the StarBright Violet Dye line with 29 additional highly validated antibodies conjugated to StarBright Violet 570, 515, 440, 670, 790 and 475 Dyes.
Now totaling 32 dyes covering multiple lasers, Bio-Rad’s StarBright Dyes line expands translational and immunological research capabilities by providing greater choice and flexibility in conventional and full-spectrum multicolor flow cytometry panels.
Bio-Rad’s line of StarBright Dyes, proprietary fluorescent nanoparticles conjugated to flow-validated antibodies against key immunological targets, offer researchers exceptional brightness with narrow excitation and emission profiles for precise analysis.
Joining StarBright Red 670, the first StarBright Red Dye, released last year, StarBright Red 715, 775 and 815 are 640 nm laser excitable and are as bright or as bright as other current comparable 640 nm excitable dyes emitting at a similar wave length . With minimal background compared to series containing cyanine dyes, StarBright Red Dyes they are also stable and can be fixed in formalin or alcohol fixatives.
StarBright Paints are compatible with most experimental protocols and flow cytometers, including Bio-Rad ZE5 Cell Analyzer, without the need for special buffers. Minimal batch-to-batch variation helps ensure reproducible and consistent staining, and the stains are resistant to photobleaching with no loss of signal during fixation.
Expanding the range of targets for humans and mice and introducing targets for dogs, cows and pigs, the additional 29 antibody markers conjugated to StarBright Violet 570, 515, 440, 670, 790 and 475 Dyes will soon be available on all StarBright Dyes.
The Bio-Rad StarBright Dye portfolio, now totaling 32 dyes in the 355, 405, 488, 561 and 640 nm lasers, is the most comprehensive dye line designed specifically for conventional and full-spectrum flow cytometry and offers superior alternatives to the existing paints. By continuing to expand our existing portfolio of antibody markers, including new targets for humans, mice, dogs, cows and pigs, we can offer our customers greater choice and flexibility when constructing multi-color panels in conventional full-spectrum flow cytometry.
Hilary Mavor, Director of Marketing, Life Science Group, Bio-Rad
To learn more about Bio-Rad StarBright Dyes and StarBright Red Dyes, visit and Red.
